New drug Leucettinib-21 enters first human safety trials
Knowledge-focused
Completed
This study is the first time Leucettinib-21 is being tested in humans. It aims to check the drug's safety and how the body processes it. The trial includes healthy volunteers and people with Down syndrome or Alzheimer's disease. No treatment benefit is expected at this early stag…
Phase: PHASE1 • Sponsor: Perha Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC